Clinical Trial Update: Menstrual Migraine Treatment With TREXIMET (Formerly Known as TREXIMA) [Phase 3]

View source ↗

Summary

Phase 3 trial of TREXIMET for menstrual migraine has completed; sponsor is GlaxoSmithKline.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• TREXIMET (sumatriptan succinate and naproxen sodium)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Migraine, Migraine Disorders | Phase 3 | Status: COMPLETED